Save information for later
Sign Up

Learn About Erythroplakia

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Erythroplakia Local Doctors?
Elite in Erythroplakia
Elite in Erythroplakia
Denmark Hill Campus, Caldecot Road, 
London, ENG, GB 

Saman Warnakulasuriya practices in London, United Kingdom. Warnakulasuriya is rated as an Elite expert by MediFind in the treatment of Erythroplakia. Their top areas of expertise are Leukoplakia, Oral Submucous Fibrosis, Erythroplakia, Lichen Planus, and Thymectomy.

Elite in Erythroplakia
Elite in Erythroplakia
Athens, ESYE31, GR 

Nikolaos Nikitakis practices in Athens, Greece. Mr. Nikitakis is rated as an Elite expert by MediFind in the treatment of Erythroplakia. His top areas of expertise are Erythroplakia, Leukoplakia, Osteonecrosis, Osteomyelitis, and Splenectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Erythroplakia
Oral and Maxillofacial Surgery | General Surgery | Otolaryngology
Distinguished in Erythroplakia
Oral and Maxillofacial Surgery | General Surgery | Otolaryngology

Rutgers University Dental Associates-New Brunswick

135 Somerset St, Suite A, 
New Brunswick, NJ 
Languages Spoken:
English, Arabic, Castilian, French, Hebrew, Hindi, Korean, Mandarin, Portuguese, Russian, Spanish, Vietnamese
Accepting New Patients

Rabie Shanti is an Oral and Maxillofacial Surgeon and a General Surgeon in New Brunswick, New Jersey. Dr. Shanti is rated as a Distinguished provider by MediFind in the treatment of Erythroplakia. His top areas of expertise are Oral Cancer, Leukoplakia, Mouth Ulcers, Osteotomy, and Gastrostomy. Dr. Shanti is currently accepting new patients.

What are the latest Erythroplakia Clinical Trials?
A Multi-Centre Prospective Community-Based Observational Study on Prediction of Malignant Progression of Clinically Suspicious Oral Lesions with STRATICYTE

Summary: The purpose of this observational study is to evaluate the utility of the S100A7 immunohistochemistry signature-based assessment - STRATICYTE - in determining the risk of progression to cancer of clinically suspicious oral lesions.

Match to trials
Find the right clinical trials for you in under a minute
Get started